Human Herpesvirus 8 (HHV-8) in the Pathogenesis of Kaposi's Sarcoma and Other Diseases

References

• Armes J. A review of Kaposi's sarcoma. Adv Cancer Res 1989; 53: 73–87
   PubMed Web of Science ®Google Scholar
• DiGiovanna J. J., Safai B. Kaposi's sarcoma. Retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases. Am J Med 1981; 71(5)779–83
   PubMed Web of Science ®Google Scholar
• McHardy J., Williams E. H., Gese A., de-The G., Beth E., Giraldo G. Endemic Kaposi's sarcoma: incidence and risk factors in the West Nile District of Uganda. Int J Cancer 1984; 33(2)203–12
   PubMed Web of Science ®Google Scholar
• Bayley A. C. Occurrence, clinical behaviour and management of Kaposi's sarcoma in Zambia. Canter Surv 1991; 10: 53–71
   PubMedGoogle Scholar
• Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993; 7(2)431–15
   PubMed Web of Science ®Google Scholar
• Brunner F. P., Landais P., Selwood N. H. Malignancies after renal transplantation: the Edta-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association. Nephrol Dial Transplant 1995; 10(1)74–80
   PubMedGoogle Scholar
• Montagnino G., Bencini P. L., Tarantino A., Caputo R., Ponticelli C. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 1994; 14(2)121–6
   PubMed Web of Science ®Google Scholar
• Beral V., Peterman T. A., Berkelman R. L., Jaffe H. W. Kaposi's sarcoma among persons with Aids: a sexually transmitted infection? [see comments]. Lancet 1990; 335(8682)123–8
   PubMed Web of Science ®Google Scholar
• Friedman-Kien A. E., Saltzman B. R., Cao Y. Z., et al. Kaposi's sarcoma in HIV-negative homosexual men [letter]. Lancet 1990; 335(8682)168–9
   PubMed Web of Science ®Google Scholar
• Afrasiab R., Mitsuyasu R. T., Nishanian P., Schwartz K., Fahey J. L. Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results. Am J Med 1986; 81(6)969–73
   PubMed Web of Science ®Google Scholar
• Giraldo G., Beth E., Huang E. S. Kaposi's sarcoma and its relationship to cytomegalovirus (Cmnv). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer 1980; 26(1)23–9
   PubMed Web of Science ®Google Scholar
• Giraldo G., Beth E., Kourilsky F. M., et al. Antibody patterns to herpesviruses in kaposi's sarcoma: serological association of european kaposi's sarcoma with cytomegalovirus. Int J Cancer 1975; 15(5)839–48
   PubMed Web of Science ®Google Scholar
• Siddiqui A. Hepatitis B virus DNA in Kaposi sarcoma. Proc Natl Acad Sci USA 1983; 80(15)4861–1
   PubMed Web of Science ®Google Scholar
• Marmor M., Friedman-Kien A. E., Laubenstein L., et al. Risk factors for Kaposi's sarcoma in homosexual men. Lancet 1982; 1(8281)1083–7
   PubMed Web of Science ®Google Scholar
• Morabia A. Poppers, Kaposi's sarcoma, and HIV infection: empirical example of a strong confounding effect. Prev Med 1995; 24: 90–95
   PubMed Web of Science ®Google Scholar
• Fiorelli V., Gendelman R., Samaniego F., Markham P. D., Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of Aids-Kaposi's sarcoma spindle cells. J Clin Invest 1995; 95(4)1723–34
   PubMed Web of Science ®Google Scholar
• Chang Y., Cesarman E., Pessin M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865–1869
   PubMed Web of Science ®Google Scholar
• Moore P., Gao S-J., Dominguez G., et al. Primary characerization of a herpesvirus agent associated with Kaposi's Sarcoma. J. Virol. 1996; 70(1)549–558
   PubMed Web of Science ®Google Scholar
• Chang Y., Moore P. S. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 1996; 5(4)215–22
   PubMedGoogle Scholar
• Nador R. G., Cesarman E., Chadburn A., et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88(2)645–56
   PubMed Web of Science ®Google Scholar
• Dupin N., Gorin I., Deleuze J., et al. Herpes-like DNA sequences, Aids-related tumors, and Castleman's disease [letter]. N Engl J Med 1995; 333(12)798, discussion 798–9
   PubMed Web of Science ®Google Scholar
• Karcher D. S., Alkan S. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease [letter; comment]. N Engl J Med 1995; 333(12)797–8, discussion 798–9
   PubMed Web of Science ®Google Scholar
• Giraldo G., Beth E., Coeur P., Vogel C. L., Dhru D. S. Kaposi's sarcoma: a new model in the search for viruses associated with human malignancies. J Natl Cancer Inst 1972; 49(6)1495–507
   PubMed Web of Science ®Google Scholar
• Giraldo G., Beth E., Kyalwazi S. K. Role of cytomegalovirus in Kaposi's sarcoma. IARC Sci Publ 1984, 63: 583–606
   PubMedGoogle Scholar
• Rady P., Yen A., Rollefson J., et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. The Lancet 1995; 345: 1339–1340
   PubMed Web of Science ®Google Scholar
• Dupin N., Grandadam M., Calvez V., et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. The Lancet 1995; 345: 761–762
   PubMed Web of Science ®Google Scholar
• Bochoff C., Whitby D., Hatziioannou T., et al. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345: 1043–44
   Web of Science ®Google Scholar
• Huang Y., Li J., Kaplan M., et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. The Lancet 1995; 345: 759–761
   PubMed Web of Science ®Google Scholar
• Schalling M., Ekman M., Kaaya E. E., Linde A., Biberfeld P. A role for a new herpes virus (Kshv) in different forms of Kaposi's sarcoma. Nat Med 1995; 1(7)707–8
   PubMed Web of Science ®Google Scholar
• Whitby D., Howard M., Tenant-Flowers M., et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346: 799–802
   PubMed Web of Science ®Google Scholar
• Moore P., Kingsley L., Holmberg S., et al. Kaposi's sarcoma-associated herpesvirus infection prior to the onset of Kaposi's sarcoma. AIDS 1995; 10: 175–180
   Web of Science ®Google Scholar
• Lin J. C., Lin S. C., Mar E. C., et al. Is Kaposi's-sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men?. Lancet. 1995; 346(8990)1601–2
   PubMed Web of Science ®Google Scholar
• Gao S-J., Kingsley L., Hoover D., et al. Seroconversion to antibodies against kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of kaposi's sarcoma. N Engl J Med 1996; 335: 233–41
   PubMed Web of Science ®Google Scholar
• Lennette E., Blackbourn D., Levy J. Antibodies to human herpesvirus type 8 in the general population and in kaposi's sarcoma patients. Lancet 1996; 348: 858–61
   PubMed Web of Science ®Google Scholar
• Davis D., Humphrey R., Newcomb F., et al. Detection of serum antibodies to a kaposi's sarcoma associated herpesvirus-specific peptide. Jour. Infect. Dis. 1997, in press
   Web of Science ®Google Scholar
• Said W., Chien K., Takeuchi S., et al. Kaposi's sarcoma-associated herpesvirus (Kshv or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood 1996; 87(12)4937–43
   PubMed Web of Science ®Google Scholar
• Corbellino M., Poirel L., Bestetti G., et al. Human herpesvirus-8 in Aids-related and unrelated lymphomas [letter]. Aids 1996; 10(5)545–6
   PubMed Web of Science ®Google Scholar
• Luppi M., Barozzi P., Maiorana A., et al. Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996; 87(9)3903–9
   PubMed Web of Science ®Google Scholar
• Humphrey R., O'Brien T., Newcomb F., et al. Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood 1996; 88: 297–301
   PubMed Web of Science ®Google Scholar
• Bigoni B., Dolcetti R., Lelli L. D., et al. Human Herpesvirus 8 is Present in the Lymphoid System of Healthy Persons and Can Reactivate in the Course of Aids. Infect. Dis. 1996; 173: 542–549
   Google Scholar
• Corbellino M., Bestetti G., Poirel L., et al. Is human herpesvirus type 8 fairly prevalent among healthy subjects in Italy? [letter]. J Infect Dis 1996; 174(3)668–70
   PubMed Web of Science ®Google Scholar
• Monini P., DeLellis L., Fabris M., Rigolin F., Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. NEJM 1996; 334: 1168–72
   PubMed Web of Science ®Google Scholar
• Ambroziak J. A., Blackbourn D. J., Herndier B. G., et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients [letter; comment]. Science 1995; 268(5210)582–3
   PubMed Web of Science ®Google Scholar
• Humphrey R., Davis D., Newcomb F., et al. Analysis of human herpesvirus-8 infection in children and adults by measuring serum antibodies to a peptide of a minor capsid protein or by PCR. J. Aids Hum. Retro. 1996, IHV Abstracts, 56
   Google Scholar
• Simpson G., Schulz T., Whitby D., et al. Prevalence of kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 349: 1133–38
   Web of Science ®Google Scholar
• Kedes D., Operskalski E., Busch M., Kohn R., Flood J., Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nature Medicine 1996; 2: 918–924
   PubMed Web of Science ®Google Scholar
• Gao S-J., Kingsley L., Li M., et al. Kshv antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med 1996; 2: 925–928
   PubMed Web of Science ®Google Scholar
• Jameson B., Wolf H. A novel algorithm, for predicting antigenic determinants. Comput Applic Biosci 1988; 4: 181–6
   PubMedGoogle Scholar
• Weller T. The cytomegalovirus: ubiquitous agents with protean clinical manifestations. N Engl J Med 1971; 285: 203–214
   PubMed Web of Science ®Google Scholar
• Morris J., Eddleston A., Crook T. Viral infection and cancer. Lancet 1995; 346: 754–758
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Smith S. D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14; 18) translocation. Cell 1986; 47(1)19–28
   PubMed Web of Science ®Google Scholar
• Moore P., Boshoff C., Weiss R., Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274: 1739–1744
   PubMed Web of Science ®Google Scholar
• Chang Y., Moore P., Talbot S., et al. Cyclin encoded by KS herpesvirus. Nature 1996; 382: 410
   PubMed Web of Science ®Google Scholar
• Russo J. J., Bohenzky R. A., Chien M. C., et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 1996; 93(25)14862–7
   PubMed Web of Science ®Google Scholar
• Soulier J., Grollet L., Oksenhendler E., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86(4)1276–80
   PubMed Web of Science ®Google Scholar
• Yoshizaki K., Matsuda T., Nishimoto N., et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74(4)1360–7
   PubMed Web of Science ®Google Scholar
• Ishiyama T., Nakamura S., Akimoto Y., et al. Immunodeficiency and IL-6 production by peripheral blood monocytes in multicentric Castleman's disease. Br. J Haematol 1994; 86(3)483–9
   PubMed Web of Science ®Google Scholar
• Giraudo E., Arese M., Toniatti C., et al. IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells. J Immunol 1996; 157(6)2618–23
   PubMed Web of Science ®Google Scholar
• Murakami-Mori K., Taga T., Kishimoto T., Nakamura S. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gpl30 is antagonistic for sIL-6R alpha-induced Aids-KS cell growth. Int Immunol 1996; 8(4)595–602
   PubMed Web of Science ®Google Scholar
• Jones K., Rivera C., Sgadari C., et al. Infection of human endothelial cells with Epstein-Barr virus. J Exp Med 1995; 182(5)1213–21
   PubMed Web of Science ®Google Scholar
• Tosato G., Tanner J., Jones K. D., Revel M., Pike S. E. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J Virol 1990; 64(6)3033–41
   PubMed Web of Science ®Google Scholar
• Tosato G., Jones K. D. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 1990; 75(6)1305–10
   PubMed Web of Science ®Google Scholar
• Oksenhendler E., Duarte M., Soulier J., et al. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. Aids 1996; 10(1)61–7
   PubMed Web of Science ®Google Scholar
• Zhong W., Wang H., Hemdier B., Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996; 93(13)6641–6
   PubMed Web of Science ®Google Scholar
• Jones J., Hanson D., Chu S., Ward J., Jaffe H. Aids-associated Kaposi's sarcoma. Science 1995; 267: 1078–1080
   PubMed Web of Science ®Google Scholar
• Costagliola D., Mary-Krause M. Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'lmmunodeficience Humaine [letter]. Lancet 1995; 346(8974)578
   PubMed Web of Science ®Google Scholar
• Morfeldt L., Torssander J. Long-term remission of Kaposi's sarcoma following foscarnet treatment of HIV-infected patients. Scad J Infect Dis 1994; 26: 749–752
   PubMed Web of Science ®Google Scholar
• Tosato G. The Epstein-Barr virus and the immune system. Adv Can Res 1987; 49: 75–125
   PubMed Web of Science ®Google Scholar
• Resnick L., Herbst J., Ablashi D. Regression of oral “hairy” leukoplakia after orally administered acyclovir therapy. JAMA 1988; 15: 384–388
   Google Scholar
• Nicholson A. G., Wotherspoon A. C., Diss T. C., et al. Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma. Histopathology 1996; 29(4)317–24
   PubMed Web of Science ®Google Scholar
• Hui P. K., Tokunaga M., Chan W. Y., Ng C. S., Chow J., Lee J. C. Epstein-Barr virus-associated gastric lymphoma in Hong Kong Chinese. Hum Pathol 1994; 25(9)947–52
   PubMed Web of Science ®Google Scholar
• Mueller N. Overview: viral agents and cancer. Environ Health Perspect 1995; 103(Suppl 8)259–61
   PubMedGoogle Scholar
• Ambinder R. F. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1. Hematol Oncol Clin North Am 1990; 4(4)821–33
   PubMed Web of Science ®Google Scholar